Literature DB >> 35608442

CT of Ovarian Cancer for Primary Treatment Planning: What the Surgeon Needs to Know-Radiology In Training.

Maria Clara Fernandes1, Ines Nikolovski1, Kara Long Roche1, Yulia Lakhman1.   

Abstract

A 60-year-old woman presented with intermittent abdominal pain, an elevated serum CA-125 level, and an abnormal CT examination and was ultimately diagnosed with advanced-stage high-grade serous ovarian cancer. Key tumor locations on CT scans that should be highlighted by the radiologist to guide treatment selection are discussed. © RSNA, 2022.

Entities:  

Mesh：

Year:  2022        PMID： 35608442      PMCID： PMC9434813          DOI： 10.1148/radiol.212737

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   29.146


  67 in total

1.  A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer.

Authors:  Johanna Hynninen; Jukka Kemppainen; Maija Lavonius; Johanna Virtanen; Jaakko Matomäki; Sinikka Oksa; Olli Carpén; Seija Grénman; Marko Seppänen; Annika Auranen
Journal:  Gynecol Oncol       Date:  2013-08-29       Impact factor: 5.482

2.  Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer.

Authors:  J Borley; C Wilhelm-Benartzi; J Yazbek; R Williamson; N Bharwani; V Stewart; I Carson; E Hird; A McIndoe; A Farthing; S Blagden; S Ghaem-Maghami
Journal:  BJOG       Date:  2014-08-05       Impact factor: 6.531

3.  Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.

Authors:  Allison E Axtell; Margaret H Lee; Robert E Bristow; Sean C Dowdy; William A Cliby; Steven Raman; John P Weaver; Mojan Gabbay; Michael Ngo; Scott Lentz; Ilana Cass; Andrew J Li; Beth Y Karlan; Christine H Holschneider
Journal:  J Clin Oncol       Date:  2007-02-01       Impact factor: 44.544

4.  Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.

Authors:  Hebert Alberto Vargas; Erich P Huang; Yulia Lakhman; Joseph E Ippolito; Priya Bhosale; Vincent Mellnick; Atul B Shinagare; Maria Anello; Justin Kirby; Brenda Fevrier-Sullivan; John Freymann; C Carl Jaffe; Evis Sala
Journal:  Radiology       Date:  2017-06-22       Impact factor: 11.105

5.  Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.

Authors:  Anna Fagotti; Gabriella Ferrandina; Giuseppe Vizzielli; Francesco Fanfani; Valerio Gallotta; Vito Chiantera; Barbara Costantini; Pasquale Alessandro Margariti; Salvatore Gueli Alletti; Francesco Cosentino; Lucia Tortorella; Giovanni Scambia
Journal:  Eur J Cancer       Date:  2016-03-19       Impact factor: 9.162

6.  A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.

Authors:  Rudy S Suidan; Pedro T Ramirez; Debra M Sarasohn; Jerrold B Teitcher; Svetlana Mironov; Revathy B Iyer; Qin Zhou; Alexia Iasonos; Harold Paul; Masayoshi Hosaka; Carol A Aghajanian; Mario M Leitao; Ginger J Gardner; Nadeem R Abu-Rustum; Yukio Sonoda; Douglas A Levine; Hedvig Hricak; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2014-07-11       Impact factor: 5.482

7.  Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).

Authors:  Anna Fagotti; Maria Gabriella Ferrandina; Giuseppe Vizzielli; Tina Pasciuto; Francesco Fanfani; Valerio Gallotta; Pasquale Alessandro Margariti; Vito Chiantera; Barbara Costantini; Salvatore Gueli Alletti; Francesco Cosentino; Giovanni Scambia
Journal:  Int J Gynecol Cancer       Date:  2020-10-07       Impact factor: 3.437

8.  Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion.

Authors:  Oguz Akin; Evis Sala; Chaya S Moskowitz; Nicole Ishill; Robert A Soslow; Dennis S Chi; Hedvig Hricak
Journal:  Radiology       Date:  2008-06-02       Impact factor: 11.105

9.  European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery.

Authors:  Denis Querleu; François Planchamp; Luis Chiva; Christina Fotopoulou; Desmond Barton; David Cibula; Giovanni Aletti; Silvestro Carinelli; Carien Creutzberg; Ben Davidson; Philip Harter; Lene Lundvall; Christian Marth; Philippe Morice; Arash Rafii; Isabelle Ray-Coquard; Andrea Rockall; Christiana Sessa; Ate van der Zee; Ignace Vergote; Andreas duBois
Journal:  Int J Gynecol Cancer       Date:  2017-09       Impact factor: 3.437
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.